BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36366956)

  • 21. Pulmonary large cell neuroendocrine carcinoma (LCNEC): a population-based study addressing recent molecular-genetic advances and emerging therapeutic approaches.
    Khan J; Yasinzai AQK; Matosz S; Khan M; Heneidi S; Mesa H; Chauhan A; Del Rivero J; Karim NA; Ullah A
    Clin Exp Med; 2023 Nov; 23(7):3947-3955. PubMed ID: 37060529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center.
    Popov P; Steindl A; Wolff L; Bergen ES; Eckert F; Frischer JM; Widhalm G; Fuereder T; Raderer M; Berghoff AS; Preusser M; Kiesewetter B
    Clin Exp Metastasis; 2024 Feb; 41(1):25-32. PubMed ID: 38064128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-derived tumoroid models of pulmonary large-cell neuroendocrine carcinoma: a promising tool for personalized medicine and developing novel therapeutic strategies.
    Yokota E; Iwai M; Yukawa T; Naomoto Y; Haisa M; Monobe Y; Takigawa N; Fukazawa T; Yamatsuji T
    Cancer Lett; 2024 Apr; 588():216816. PubMed ID: 38499265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC).
    Sherman S; Rotem O; Shochat T; Zer A; Moore A; Dudnik E
    Lung Cancer; 2020 May; 143():40-46. PubMed ID: 32203769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of lung large cell neuroendocrine carcinoma.
    Lo Russo G; Pusceddu S; Proto C; Macerelli M; Signorelli D; Vitali M; Ganzinelli M; Gallucci R; Zilembo N; Platania M; Buzzoni R; de Braud F; Garassino MC
    Tumour Biol; 2016 Jun; 37(6):7047-57. PubMed ID: 26943800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
    Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
    J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survivor of pulmonary combined large cell neuroendocrine carcinoma treated with nivolumab.
    Oda R; Okuda K; Yamashita Y; Sakane T; Tatematsu T; Yokota K; Endo K; Nakanishi R
    Thorac Cancer; 2020 Jul; 11(7):2036-2039. PubMed ID: 32379390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage.
    Lowczak A; Kolasinska-Cwikla A; Osowiecka K; Glinka L; Palucki J; Rzepko R; Doboszynska A; Cwikla JB
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33525370
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
    Abedallaa N; Tremblay L; Baey C; Fabre D; Planchard D; Pignon JP; Guigay J; Pechoux CL; Soria JC; de Montpreville VT; Besse B
    J Thorac Oncol; 2012 Jul; 7(7):1179-83. PubMed ID: 22617247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment options for patients with large cell neuroendocrine carcinoma of the lung.
    Iyoda A; Makino T; Koezuka S; Otsuka H; Hata Y
    Gen Thorac Cardiovasc Surg; 2014 Jun; 62(6):351-6. PubMed ID: 24719260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma.
    Zhuo M; Guan Y; Yang X; Hong L; Wang Y; Li Z; Chen R; Abbas HA; Chang L; Gong Y; Wu N; Zhong J; Chen W; Chen H; Dong Z; Zhu X; Li J; Wang Y; An T; Wu M; Wang Z; Wang J; Roarty EB; Rinsurongkawong W; Lewis J; Roth JA; Swisher SG; Lee JJ; Heymach JV; Wistuba II; Kalhor N; Yang L; Yi X; Futreal PA; Glisson BS; Xia X; Zhang J; Zhao J
    Clin Cancer Res; 2020 Feb; 26(4):892-901. PubMed ID: 31694833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
    Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
    Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung.
    Rossi G; Cavazza A; Marchioni A; Longo L; Migaldi M; Sartori G; Bigiani N; Schirosi L; Casali C; Morandi U; Facciolongo N; Maiorana A; Bavieri M; Fabbri LM; Brambilla E
    J Clin Oncol; 2005 Dec; 23(34):8774-85. PubMed ID: 16314638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment with temozolomide in an elderly woman with advanced pulmonary large-cell neuroendocrine carcinoma: A case report.
    Wei J; Dong XF; Hu ZL; Tang S; Lu YF
    Medicine (Baltimore); 2018 Dec; 97(51):e13318. PubMed ID: 30572435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroendocrine tumors of the lung: A five-year retrospective experience of Egyptian NCI (2010-2014).
    Saber M; Ismail Y; Alieldin N; Loay I; El Zawahry M
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):151-158. PubMed ID: 30470605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary Large Cell Neuroendocrine Carcinoma.
    Yang L; Fan Y; Lu H
    Pathol Oncol Res; 2022; 28():1610730. PubMed ID: 36304941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of a deep learning algorithm to distinguish large cell neuroendocrine from small cell lung carcinoma in cytology specimens.
    Gonzalez D; Dietz RL; Pantanowitz L
    Cytopathology; 2020 Sep; 31(5):426-431. PubMed ID: 32246504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological diagnosis of pulmonary large cell neuroendocrine carcinoma by endobronchial ultrasound-guided transbronchial needle aspiration.
    Inage T; Nakajima T; Fujiwara T; Sakairi Y; Wada H; Suzuki H; Iwata T; Chiyo M; Nakatani Y; Yoshino I
    Thorac Cancer; 2018 Feb; 9(2):273-277. PubMed ID: 29271588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differences of biological behavior based on the clinicopathological data between resectable large-cell neuroendocrine carcinoma and small-cell lung carcinoma.
    Kinoshita T; Yoshida J; Ishii G; Aokage K; Hishida T; Nagai K
    Clin Lung Cancer; 2013 Sep; 14(5):535-40. PubMed ID: 23792008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the Lung.
    Buium C; Negru S; Ionescu DN; Dediu M
    Curr Oncol; 2023 Jul; 30(8):7218-7228. PubMed ID: 37623004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.